• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Ellen Barry
Author: Ellen Barry

Written by

Ellen Barry

in

Clinical Trials, Dopamine, Drugs (Pharmaceuticals), Food and Drug Administration, Karuna Therapeutics Inc, Psychiatry and Psychiatrists, Psychology and Psychologists, Regulation and Deregulation of Industry, Research, Schizophrenia, Therapy and Rehabilitation
←Museum at FIT Tells the Story of the African Diaspora Through Its Fashions
Inside the U.N. Dinner Party at Eleven Madison Park→

More posts

  • The Oscars are usually wrong. Here are the real best pictures.

  • How to Create Your Own Affordable Wellness Vacation.

  • Voters head to the polls for special election in Marjorie Taylor Greene’s Georgia district

  • Australia grants asylum to five Iranian soccer players

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube